Return to Article Details
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
Download
Download PDF
นโยบายการคุ้มครองข้อมูลส่วนบุคคล
Privacy policy